isoxazoles has been researched along with Gastroduodenal Ulcer in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (90.91) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, NM; Kent, JD; Recker, DP; Sikes, DH; Verburg, KM; Zhao, WW | 1 |
| Pavelka, K; Recker, DP; Verburg, KM | 1 |
| Niculescu, L; Peña, B; von Scheele, B; Wong, J | 1 |
| Agrawal, N; Eisen, GM; Goldstein, JL; Kent, JD; Stenson, WF; Verburg, KM | 1 |
| Kellner, H | 1 |
| Epstein, J; Klasser, GD | 1 |
| Goldstein, JL; Harris, SI; Hubbard, RC; Kuss, M | 1 |
| Shaughnessy, AF | 1 |
| DiPasquale, G; Gingold, J; Rassaert, C; Richter, R; Singer, R; Welaj, P | 1 |
2 review(s) available for isoxazoles and Gastroduodenal Ulcer
| Article | Year |
|---|---|
Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Humans; Isoenzymes; Isoxazoles; Male; Membrane Proteins; Middle Aged; Multicenter Studies as Topic; Osteoarthritis; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Randomized Controlled Trials as Topic; Sulfonamides | 2004 |
Nonsteroidal anti-inflammatory drugs: confusion, controversy and dental implications.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Humans; Isoxazoles; Lactones; Myocardial Infarction; Peptic Ulcer; Pyrazoles; Sulfonamides; Sulfones; Toothache | 2005 |
4 trial(s) available for isoxazoles and Gastroduodenal Ulcer
| Article | Year |
|---|---|
Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Diclofenac; Double-Blind Method; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Ibuprofen; Isoenzymes; Isoxazoles; Male; Membrane Proteins; Middle Aged; Osteoarthritis; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Stomach Ulcer; Sulfonamides; Treatment Outcome | 2002 |
Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Female; Humans; Isoenzymes; Isoxazoles; Male; Membrane Proteins; Middle Aged; Pain Measurement; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Treatment Outcome | 2003 |
Economic evaluation of oral valdecoxib versus diclofenac in the treatment of patients with rheumatoid arthritis in a randomized clinical trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cohort Studies; Cost Savings; Cost-Benefit Analysis; Diclofenac; Drug Costs; Female; Health Resources; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Peptic Ulcer; Sulfonamides | 2003 |
Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo.
Topics: Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Gastric Mucosa; Humans; Infusions, Parenteral; Isoenzymes; Isoxazoles; Ketorolac; Male; Membrane Proteins; Naproxen; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases | 2001 |
5 other study(ies) available for isoxazoles and Gastroduodenal Ulcer
| Article | Year |
|---|---|
[Adverse effect-free analgesia. New COX-2 inhibitor is even more selective].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Isoxazoles; Membrane Proteins; Pain; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Treatment Outcome | 2003 |
[Current EULAR data on valdecoxib. New study results of gastrointestinal safety and "cost effectiveness"].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cost-Benefit Analysis; Cyclooxygenase Inhibitors; Drug Costs; Germany; Humans; Isoxazoles; Osteoarthritis; Peptic Ulcer; Product Surveillance, Postmarketing; Risk Factors; Sulfonamides | 2004 |
Valdecoxib (Bextra)--a new cox-2 inhibitor.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Humans; Isoxazoles; Kidney Diseases; Osteoarthritis; Peptic Ulcer; Sulfonamides | 2002 |
Right ballpark, wrong base: assessing safety of NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Isoxazoles; Lactones; Naproxen; Osteoarthritis; Peptic Ulcer; Sulfonamides; Sulfones | 2002 |
The anti=inflammatory properties of isoxicam (4-hydroxy-2methyl-N-(5-methyl-3isoxolyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide).
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Carrageenan; Inflammation; Isoxazoles; Male; Oxazoles; Peptic Ulcer; Piroxicam; Rats; Thiazines | 1975 |